Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Peptic Ulcer

  Free Subscription

Articles published in Gut

Retrieve available abstracts of 42 articles:
HTML format
Text format

Single Articles

    February 2018
  1. PENG YC, Huang LR, Lin CL, Hsu WY, et al
    Association between proton pump inhibitors use and risk of gastric cancer in patients with GERD.
    Gut. 2018 Feb 22. pii: gutjnl-2018-316057. doi: 10.1136/gutjnl-2018-316057.
    PubMed     Text format    

    January 2018
  2. DOORAKKERS E, Lagergren J, Engstrand L, Brusselaers N, et al
    Helicobacter pylori eradication treatment and the risk of gastric adenocarcinoma in a Western population.
    Gut. 2018 Jan 30. pii: gutjnl-2017-315363. doi: 10.1136/gutjnl-2017-315363.
    PubMed     Text format     Abstract available

  3. SUISSA S, Suissa A
    Proton-pump inhibitors and increased gastric cancer risk: time-related biases.
    Gut. 2018 Jan 3. pii: gutjnl-2017-315729. doi: 10.1136/gutjnl-2017-315729.
    PubMed     Text format    

    December 2017
  4. NIIKURA R, Hayakawa Y, Hirata Y, Yamada A, et al
    Long-term proton pump inhibitor use is a risk factor of gastric cancer after treatment for Helicobacter pylori: a retrospective cohort analysis.
    Gut. 2017 Dec 22. pii: gutjnl-2017-315710. doi: 10.1136/gutjnl-2017-315710.
    PubMed     Text format    

  5. SUZUKI H, Matsuzaki J
    Helicobacter pylori eradication failure may have confounded the recent large-scale health database study that showed proton pump inhibitors increase gastric cancer risk.
    Gut. 2017 Dec 15. pii: gutjnl-2017-315698. doi: 10.1136/gutjnl-2017-315698.
    PubMed     Text format    

    November 2017
  6. GUETA I, Halkin H, Markovits N, Loebstein R, et al
    Proton pump inhibitors and the risk for gastric cancer: possible confounding by serum vitamin B 12.
    Gut. 2017 Nov 28. pii: gutjnl-2017-315695. doi: 10.1136/gutjnl-2017-315695.
    PubMed     Text format    

  7. WALDUM HL, Fossmark R
    Proton pump inhibitors and gastric cancer: a long expected side effect finally reported also in man.
    Gut. 2017 Nov 20. pii: gutjnl-2017-315629. doi: 10.1136/gutjnl-2017-315629.
    PubMed     Text format    

    October 2017
  8. CHEUNG KS, Chan EW, Wong AYS, Chen L, et al
    Long-term proton pump inhibitors and risk of gastric cancer development after treatment for Helicobacter pylori: a population-based study.
    Gut. 2017 Oct 31. pii: gutjnl-2017-314605. doi: 10.1136/gutjnl-2017-314605.
    PubMed     Text format     Abstract available

  9. REVELES KR, Ryan CN, Chan L, Cosimi RA, et al
    Proton pump inhibitor use associated with changes in gut microbiota composition.
    Gut. 2017 Oct 9. pii: gutjnl-2017-315306. doi: 10.1136/gutjnl-2017-315306.
    PubMed     Text format    

  10. MIZOKAMI Y, Oda K, Funao N, Nishimura A, et al
    Vonoprazan prevents ulcer recurrence during long-term NSAID therapy: randomised, lansoprazole-controlled non-inferiority and single-blind extension study.
    Gut. 2017 Oct 7. pii: gutjnl-2017-314010. doi: 10.1136/gutjnl-2017-314010.
    PubMed     Text format     Abstract available

    September 2017
    Illusions regarding Helicobacter pylori clinical trials and treatment guidelines.
    Gut. 2017 Sep 21. pii: gutjnl-2017-314744. doi: 10.1136/gutjnl-2017-314744.
    PubMed     Text format    

  12. NOTO JM, Chopra A, Loh JT, Romero-Gallo J, et al
    Pan-genomic analyses identify key Helicobacter pylori pathogenic loci modified by carcinogenic host microenvironments.
    Gut. 2017 Sep 18. pii: gutjnl-2017-313863. doi: 10.1136/gutjnl-2017-313863.
    PubMed     Text format     Abstract available

  13. HUO X, Agoston AT, Dunbar KB, Cipher DJ, et al
    Hypoxia-inducible factor-2alpha plays a role in mediating oesophagitis in GORD.
    Gut. 2017;66:1542-1554.
    PubMed     Text format     Abstract available

    August 2017
  14. VOHLONEN IJ, Hakama M, Harkonen M, Malila N, et al
    Oesophageal cancer incidence in 20-year follow-up in a population-based sample of 12 000 middle-age men with or without Helicobacter pylori infection in Finland.
    Gut. 2017 Aug 31. pii: gutjnl-2017-314913. doi: 10.1136/gutjnl-2017-314913.
    PubMed     Text format    

    June 2017
  15. MERA RM, Bravo LE, Camargo MC, Bravo JC, et al
    Dynamics of Helicobacter pylori infection as a determinant of progression of gastric precancerous lesions: 16-year follow-up of an eradication trial.
    Gut. 2017 Jun 24. pii: gutjnl-2016-311685. doi: 10.1136/gutjnl-2016-311685.
    PubMed     Text format     Abstract available

  16. LIN PY, Tang JH, Chang CC
    A rare cause of GI bleeding in a 56-year-old man.
    Gut. 2017;66:1074.
    PubMed     Text format    

    May 2017
  17. SIERRA JC, Asim M, Verriere TG, Piazuelo MB, et al
    Epidermal growth factor receptor inhibition downregulates Helicobacter pylori-induced epithelial inflammatory responses, DNA damage and gastric carcinogenesis.
    Gut. 2017 May 4. pii: gutjnl-2016-312888. doi: 10.1136/gutjnl-2016-312888.
    PubMed     Text format     Abstract available

    April 2017
  18. HOUGHTON LA, Smith JA
    Gastro-oesophageal reflux events: just another trigger in chronic cough?
    Gut. 2017 Apr 25. pii: gutjnl-2017-314027. doi: 10.1136/gutjnl-2017-314027.
    PubMed     Text format    

  19. LORD AR, Simms LA, Hanigan K, Sullivan R, et al
    Protective effects of Helicobacter pylori for IBD are related to the cagA-positive strain.
    Gut. 2017 Apr 13. pii: gutjnl-2017-313805. doi: 10.1136/gutjnl-2017-313805.
    PubMed     Text format    

    February 2017
  20. EUSEBI LH, Ratnakumaran R, Yuan Y, Solaymani-Dodaran M, et al
    Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysis.
    Gut. 2017 Feb 23. pii: gutjnl-2016-313589. doi: 10.1136/gutjnl-2016-313589.
    PubMed     Text format     Abstract available

    December 2016
  21. OTSUKA T, Sugimoto M, Inoue R, Ohno M, et al
    Influence of potassium-competitive acid blocker on the gut microbiome of Helicobacter pylori-negative healthy individuals.
    Gut. 2016 Dec 13. pii: gutjnl-2016-313312. doi: 10.1136/gutjnl-2016-313312.
    PubMed     Text format    

    October 2016
    NF-kappaB mediated transcription of DARPP-32 prevents Helicobacter pylori-induced cell death.
    Gut. 2016 Oct 27. pii: gutjnl-2016-312822. doi: 10.1136/gutjnl-2016-312822.
    PubMed     Text format    

  23. MALFERTHEINER P, Megraud F, O'Morain CA, Gisbert JP, et al
    Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report.
    Gut. 2016 Oct 5. pii: gutjnl-2016-312288. doi: 10.1136/gutjnl-2016-312288.
    PubMed     Text format     Abstract available

    September 2016
  24. YEO YH, Shiu SI, Ho HJ, Zou B, et al
    First-line Helicobacter pylori eradication therapies in countries with high and low clarithromycin resistance: a systematic review and network meta-analysis.
    Gut. 2016 Sep 26. pii: gutjnl-2016-311868. doi: 10.1136/gutjnl-2016-311868.
    PubMed     Text format     Abstract available

  25. MOLINA-INFANTE J, Hirano I, Spechler SJ
    Clarifying misunderstandings and misinterpretations about proton pump inhibitor-responsive oesophageal eosinophilia.
    Gut. 2016 Sep 13. pii: gutjnl-2016-312851. doi: 10.1136/gutjnl-2016-312851.
    PubMed     Text format    

  26. ZHU S, Soutto M, Chen Z, Peng D, et al
    Helicobacter pylori-induced cell death is counteracted by NF-kappaB-mediated transcription of DARPP-32.
    Gut. 2016 Sep 2. pii: gutjnl-2016-312141. doi: 10.1136/gutjnl-2016-312141.
    PubMed     Text format     Abstract available

    July 2016
  27. MUIR AB, Wang ML, Metz D, Falk G, et al
    Proton pump inhibitor-responsive oesophageal eosinophilia: too early to change clinical practice.
    Gut. 2016 Jul 26. pii: gutjnl-2016-312601. doi: 10.1136/gutjnl-2016-312601.
    PubMed     Text format    

    June 2016
  28. FOCK KM, Talley N, Goh KL, Sugano K, et al
    Asia-Pacific consensus on the management of gastro-oesophageal reflux disease: an update focusing on refractory reflux disease and Barrett's oesophagus.
    Gut. 2016 Jun 3. pii: gutjnl-2016-311715. doi: 10.1136/gutjnl-2016-311715.
    PubMed     Text format     Abstract available

    May 2016
  29. KATAYAMA Y, Toyoda K, Kusano Y, Suda T, et al
    Efficacy of vonoprazan-based second-line Helicobacter pylori eradication therapy in patients for whom vonoprazan-based fi rst-line treatment failed.
    Gut. 2016 May 17. pii: gutjnl-2016-312028. doi: 10.1136/gutjnl-2016-312028.
    PubMed     Text format    

    April 2016
  30. MEJIAS-LUQUE R, Zoller J, Anderl F, Loew-Gil E, et al
    Lymphotoxin beta receptor signalling executes Helicobacter pylori-driven gastric inflammation in a T4SS-dependent manner.
    Gut. 2016 Apr 13. pii: gutjnl-2015-310783. doi: 10.1136/gutjnl-2015-310783.
    PubMed     Text format     Abstract available

    Vonoprazan Helicobacter pylori eradication therapy: ethical and interpretation issues.
    Gut. 2016 Apr 7. pii: gutjnl-2016-311796. doi: 10.1136/gutjnl-2016-311796.
    PubMed     Text format    

    March 2016
  32. MURAKAMI K, Sakurai Y, Shiino M, Funao N, et al
    Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind study.
    Gut. 2016 Mar 2. pii: gutjnl-2015-311304. doi: 10.1136/gutjnl-2015-311304.
    PubMed     Text format     Abstract available

    February 2016
  33. DORE MP, Lu H, Graham DY
    Role of bismuth in improving Helicobacter pylori eradication with triple therapy.
    Gut. 2016 Feb 4. pii: gutjnl-2015-311019. doi: 10.1136/gutjnl-2015-311019.
    PubMed     Text format     Abstract available

    December 2015
  34. JACKSON MA, Goodrich JK, Maxan ME, Freedberg DE, et al
    Proton pump inhibitors alter the composition of the gut microbiota.
    Gut. 2015 Dec 30. pii: gutjnl-2015-310861. doi: 10.1136/gutjnl-2015-310861.
    PubMed     Text format     Abstract available

  35. MOLINA-INFANTE J, Bredenoord AJ, Cheng E, Dellon ES, et al
    Proton pump inhibitor-responsive oesophageal eosinophilia: an entity challenging current diagnostic criteria for eosinophilic oesophagitis.
    Gut. 2015 Dec 18. pii: gutjnl-2015-310991. doi: 10.1136/gutjnl-2015-310991.
    PubMed     Text format     Abstract available

  36. IMHANN F, Bonder MJ, Vich Vila A, Fu J, et al
    Proton pump inhibitors affect the gut microbiome.
    Gut. 2015 Dec 9. pii: gutjnl-2015-310376. doi: 10.1136/gutjnl-2015-310376.
    PubMed     Text format     Abstract available

    September 2015
  37. LIOU JM, Chen CC, Chang CY, Chen MJ, et al
    Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Helicobacter pylori in the community and hospital populations: a randomised trial.
    Gut. 2015 Sep 3. pii: gutjnl-2015-310142. doi: 10.1136/gutjnl-2015-310142.
    PubMed     Text format     Abstract available

  38. ZHANG W, Chen Q, Liang X, Liu W, et al
    Bismuth, lansoprazole, amoxicillin and metronidazole or clarithromycin as first-line Helicobacter pylori therapy.
    Gut. 2015 Sep 2. pii: gutjnl-2015-309900. doi: 10.1136/gutjnl-2015-309900.
    PubMed     Text format     Abstract available

    July 2015
  39. SUGANO K, Tack J, Kuipers EJ, Graham DY, et al
    Kyoto global consensus report on Helicobacter pylori gastritis.
    Gut. 2015 Jul 17. pii: gutjnl-2015-309252. doi: 10.1136/gutjnl-2015-309252.
    PubMed     Text format     Abstract available

    May 2015
  40. PAN KF, Zhang L, Gerhard M, Ma JL, et al
    A large randomised controlled intervention trial to prevent gastric cancer by eradication of Helicobacter pylori in Linqu County, China: baseline results and factors affecting the eradication.
    Gut. 2015 May 18. pii: gutjnl-2015-309197. doi: 10.1136/gutjnl-2015-309197.
    PubMed     Text format     Abstract available

  41. WANG XY, Dai YH, Yang YM
    Unusual cause of a giant antral ulcer.
    Gut. 2015;64:730.
    PubMed     Text format    

    April 2015
  42. NG GZ, Menheniott TR, Every AL, Stent A, et al
    The MUC1 mucin protects against Helicobacter pylori pathogenesis in mice by regulation of the NLRP3 inflammasome.
    Gut. 2015 Apr 8. pii: gutjnl-2014-307175. doi: 10.1136/gutjnl-2014-307175.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Peptic Ulcer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.